Medicinal Products

Mircera

The medicinal product has been authorised by the European Commission (EC) via centralised procedure in all EU Member States, based on the European Medicines Agency (EMA) experts' opinion.

Name Mircera
Active Substance metoksi polietilenglikol-epoetin beta
Prescription Medicinal product subject to medical prescription
Type of prescription ograničeni recept
Distribution Supply through pharmacies (community)
ATC Code B03XA03
Marketing status stavljeno u promet
Shortage status nema nestašice
Summary of product characteristics (SmPC), labelling and package leaflet (PL) download
Link to the European Medicines Agency's (EMA) product information download
Link to the European Commission's (EC) decisions download
Educational materials
for healthcare professionals
Vodič za liječnike, verzija 2

Packaging

Direct Healthcare Professional Communication

Name Date Download
Pismo zdravstvenim radnicima o novim upozorenjima o teškim kožnim nuspojavama lijekova koji sadrže humane epoetine 29.09.2017 Amgen d.o.o., Pfizer Croatia d.o.o., Pliva Hrvatska d.o.o., Roche d.o.o. i Sandoz d.o.o.
Back